59 related articles for article (PubMed ID: 23805980)
21. Modulating multidrug resistance gene in leukaemia cells by short interfering RNA.
Lim MN; Lau NS; Chang KM; Leong CF; Zakaria Z
Singapore Med J; 2007 Oct; 48(10):932-8. PubMed ID: 17909680
[TBL] [Abstract][Full Text] [Related]
22. Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML.
Beck J; Handgretinger R; Klingebiel T; Dopfer R; Schaich M; Ehninger G; Niethammer D; Gekeler V
Leukemia; 1996 Mar; 10(3):426-33. PubMed ID: 8642857
[TBL] [Abstract][Full Text] [Related]
23. Methods for detection of MDR1 mRNA expression on acute myelogenous leukemia cells.
Sato H; Oonishi T; Wada C
Kitasato Arch Exp Med; 1993 Apr; 65 Suppl():25-36. PubMed ID: 7967378
[TBL] [Abstract][Full Text] [Related]
24. [A clinical study on multidrug resistance gene (MDR1) expression in acute leukemia].
Pu J; Liu H; Lou F
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):655-8. PubMed ID: 8731823
[TBL] [Abstract][Full Text] [Related]
25. Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia.
Gruber A; Vitols S; Norgren S; Areström I; Peterson C; Björkholm M; Reizenstein P; Luthman H
Br J Cancer; 1992 Aug; 66(2):266-72. PubMed ID: 1380280
[TBL] [Abstract][Full Text] [Related]
26. Association of Multidrug Resistance Gene-1 (MDR1 C1236T) Polymorphism with the Risk of Acute Myeloid Leukemia in a Moroccan Population.
Ait Boujmia OK; Nadifi S; Dehbi H; Lamchahab M; Quessar A
Asian Pac J Cancer Prev; 2020 Jul; 21(7):1899-1904. PubMed ID: 32711413
[TBL] [Abstract][Full Text] [Related]
27. The impact of matched and mismatched donor-recipient genotypes for MDR1 polymorphisms (G2677TA, C1236T and C3435T) on the outcomes of patients after allogeneic haematopoietic stem cell transplantation.
Duan Z; Zhang X; Liu Y; Wang J; Zhu H; Chen R; Xu W; Miao K
Br J Haematol; 2024 Jun; ():. PubMed ID: 38924031
[TBL] [Abstract][Full Text] [Related]
28. BCL11A and MDR1 expressions have prognostic impact in patients with acute myeloid leukemia treated with chemotherapy.
Xutao G; PengCheng S; Yin L; Huijuan D; Yan W; Haiqing Z; Bing X
Pharmacogenomics; 2018 Mar; 19(4):343-348. PubMed ID: 29469608
[TBL] [Abstract][Full Text] [Related]
29. Searching for polymorphisms that affect gene expression and mRNA processing: example ABCB1 (MDR1).
Wang D; Sadée W
AAPS J; 2006 Aug; 8(3):E515-20. PubMed ID: 17025270
[TBL] [Abstract][Full Text] [Related]
30. MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia.
Sato H; Preisler H; Day R; Raza A; Larson R; Browman G; Goldberg J; Vogler R; Grunwald H; Gottlieb A
Br J Haematol; 1990 Jul; 75(3):340-5. PubMed ID: 1696833
[TBL] [Abstract][Full Text] [Related]
31. A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia.
Lee SI; Celik S; Logsdon BA; Lundberg SM; Martins TJ; Oehler VG; Estey EH; Miller CP; Chien S; Dai J; Saxena A; Blau CA; Becker PS
Nat Commun; 2018 Jan; 9(1):42. PubMed ID: 29298978
[TBL] [Abstract][Full Text] [Related]
32. Hepatocyte prostaglandin synthesis and Mdr1 expression.
Johnston DE
Hepatology; 2002 Aug; 36(2):510-1; author reply 511-2. PubMed ID: 12143066
[No Abstract] [Full Text] [Related]
33. Drug resistance: Overcoming resistance in acute myeloid leukaemia treatment.
Lokody I
Nat Rev Cancer; 2014 Jul; 14(7):452-3. PubMed ID: 24957938
[No Abstract] [Full Text] [Related]
34. MDR1 and LPL genetic variants are associated with unfavorable outcome in stroke patients under atorvastatin treatment.
Della-Morte D; Guadagni F; Palmirotta R; Ferroni P; Rundek T
Pharmacogenomics; 2013 Jan; 14(1):14-5. PubMed ID: 23379020
[No Abstract] [Full Text] [Related]
35. Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy.
Rodríguez-Macías G; Briz O; Cives-Losada C; Chillón MC; Martínez-Laperche C; Martínez-Arranz I; Buño I; González-Díaz M; Díez-Martín JL; Marin JJG; Macias RIR
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370755
[TBL] [Abstract][Full Text] [Related]
36. MDR1 Gene Polymorphisms and Its Association With Expression as a Clinical Relevance in Terms of Response to Chemotherapy and Prognosis in Ovarian Cancer.
Haque A; Sait KHW; Alam Q; Alam MZ; Anfinan N; Wali AWN; Rasool M
Front Genet; 2020; 11():516. PubMed ID: 32528530
[TBL] [Abstract][Full Text] [Related]
37. Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines.
Karai E; Szebényi K; Windt T; Fehér S; Szendi E; Dékay V; Vajdovich P; Szakács G; Füredi A
Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32365663
[TBL] [Abstract][Full Text] [Related]
38. The FLT3 inhibitor midostaurin selectively resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
Hsiao SH; Lusvarghi S; Huang YH; Ambudkar SV; Hsu SC; Wu CP
Cancer Lett; 2019 Mar; 445():34-44. PubMed ID: 30639533
[TBL] [Abstract][Full Text] [Related]
39. Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways.
Chen L; Zhang YH; Wang S; Zhang Y; Huang T; Cai YD
PLoS One; 2017; 12(9):e0184129. PubMed ID: 28873455
[TBL] [Abstract][Full Text] [Related]
40. Loss of constitutive
Delou JMA; Vignal GM; Índio-do-Brasil V; Accioly MTS; da Silva TSL; Piranda DN; Sobral-Leite M; de Carvalho MA; Capella MAM; Vianna-Jorge R
Breast Cancer (Dove Med Press); 2017; 9():415-428. PubMed ID: 28670140
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
